Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Biomet Opposes MDL for M2A-Magnum Hip Replacement Lawsuits August 6, 2012 Austin Kirk Add Your Comments Although a growing number of individuals throughout the United States have filed a Biomet M2A-Magnum hip replacement lawsuit after experiencing problems with the metal-on-metal implant, the manufacturer indicates that they are opposed to consolidation of the cases in federal court as part of an MDL, or multidistrict litigation. In late June, a motion was filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking to consolidate and centralize the Biomet hip lawsuits before one judge for coordinated management during pre-trial proceedings. Plaintiffs who filed the motion identified at least nine product liability lawsuits filed against Biomet in U.S. District Courts throughout the country over problems with the M2A Magnum metal-on-metal hip replacement, which features a metal ball rotating within a metal cup. All of the complaints involve similar allegations that the design allows microscopic shavings of metal to be released into the body, which increase the risk of loosening or failure of the implant. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a response (PDF) filed on July 19, Biomet suggested that the formation of a M2A-Magnum MDL was not appropriate because the cases will be dominated by the specific circumstances of each case and the manufacturer claims that they have a track record of reaching Biomet Magnum settlement agreements or obtaining other resolutions for claims Biomet Magnum MDL Not Needed, Manufacturer Claims Consolidation of cases as part of an MDL is common in complex product liability lawsuits where a large number of complaints have been filed over the same or similar medical devices. At least three other MDLs have already been established for other metal-on-metal hip replacements that have been linked to similar problems, including the DePuy ASR hip, DePuy Pinnacle hip and Wright Conserve hip. Since the motion was filed to establish a Biomet Magnum MDL, the number of federal lawsuits over the artificial hip implant has already grown to include at least 40 cases. Biomet acknowledges that there are now 23 properly commenced lawsuits over the M2A-Magnum hip replacement that have yet to reach a resolution, and the manufacturer is aware of at least another 17 cases that have been filed but not yet served. However, the manufacturer claims that all of the complaints have been filed by only five firms, who all have leadership roles in existing hip replacement MDLs. The manufacturer has suggested that the filing of the request for an MDL was merely an attempt by lawyers reviewing potential cases to increase the number of lawsuits. In opposing the MDL, Biomet argues that the consolidation of the lawsuits is not appropriate because the cases will require heavily individualizd discovery, which defeats the purpose of centralizing cases involving common issues. In addition, the manufacturer suggests that many of the cases are already at an advanced stage in the litigation, and settlements or other resolutions have already been reached in a number of cases. The first Biomet Magnum lawsuit was filed in July 2008, according to the manufacturer. However, that case was terminated based on summary judgment in 2009. The manufacturer reports that at least five other cases filed have already settled or been dismissed, suggesting that Biomet’s track record of resolving Magnum Actions “expeditiously” weighs against consolidation. Although Biomet opposes creation of an MDL for the M2A-Magnum hip replacement lawsuits, they have suggested that if the panel decides that one is appropriate, the litigation should be transferred to the Southern District of New York or the District of New Jersey. Plaintiffs have proposed the Northern District of California, with the Southern District of New York identified as an alternate proposal. Oral arguments on the motion are expected to be heard at the next hearing session for the U.S. JPML, which will be held at the Daniel Patric Moyniham U.S. Courthouse in New York, New York on September 20. Tags: Biomet, Biomet M2A Magnum, Metal Hip Replacement, Metal-on-Metal Hip, Metal-on-Metal Hip Replacement, Metallosis Image Credit: | More Lawsuit Stories Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials April 2, 2025 Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025 Artificial Stone Cutter Files Lawsuit Over Silicosis Lung Disease April 2, 2025 1 Comments David September 23, 2012 I have a Biomet total hip implant. This was was done in 2006. The first 2 yrs where good, after that it has been down hill ever since. I pray that Biomet, Courts, get off there dead asses and do some thing. We are in pain not them. And they still will make a fortune off us. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)